News & Events
Best wishes for the festive season and the year 2025!
D-BSSE wishes all members and friends Merry Christmas and a Happy and Peaceful Year 2025! At the Townhall on 28 January, we will review the year 2024 and look into the future, putting a spotlight on our quest to advance molecular and cellular systems engineering and its translation into medicine and other applications. Until then: Stay safe and all the vey best!
Scientific retreat highlights innovative collaborations and cutting-edge research across academia and industry
The recent scientific retreat for the ETH Zurich-Roche partnership, Next-gen Bioengineers, brought together a dynamic mix of researchers, scientists, programme sponsors, and distinguished guests to foster innovation and collaboration and reflect on the successful first year of the programmes. The event featured insightful presentations and chalktalks, inspirational keynotes and forward-looking plenary sessions aimed at bridging the gap between academia and industry.
Precision light-controlled tissue engineering paves the way for advanced 2D and 3D cellular models
In two pioneering studies published in Nature Communications, researchers unveil novel light-based technologies to control cellular behaviour with unprecedented accuracy. Led by Mustafa Khammash, head of the Control Theory and Systems Biology Lab at D-BSSE, and Matias Zurbriggen at Heinrich-Heine University Düsseldorf, these studies showcase a great advancement in synthetic biology by using light to guide cell behaviour in engineered two- and three-dimensional tissues.
Meet David Schnettler studying the origin of polymerases
The German biochemist is fascinated by the complexity of enzymes and their functionality as catalysts. Holding a NOMIS-ETH fellowship he chose the Bioprocess Lab (“great vibes!”) for his postdoctoral research on the origin and evolution of early enzymes. In his free time, he loves participating in races – on his two legs and on two wheels.
Karl-Heinz Hoffmann Prize for Tanja Stadler
At this year’s annual ceremony, the Bavarian Academy of Sciences and Humanities honoured Tanja Stadler with the Karl-Heinz Hoffmann Prize. Founded by the German entrepreneur Ulrich L. Rohde, the prize awards distinguished research in applied mathematics. Tanja’s research in computational evolution combines mathematics, computer sciences, evolution, ecology, and epidemiology. Congratulations!
Paradigm shift in biological research: Cells turn into autobiographers
Led by researchers from the Computational Evolution group of Tanja Stadler in collaboration with colleagues at the Biozentrum, University of Basel, and the US-institutions University of Washington and California Institute of Technology, a recently published Perspective in Nature Reviews Genetics explores a revolutionary concept in biology: using DNA to record the history and behaviour of individual cells over time.
Meet ESOP-fellow Thomas Zimmermann
Every year, up to thousand candidates apply for ETH Zurich’s Excellence Scholarship and Opportunity Programme (ESOP), between 50 and 60 applicants are awarded the prestigious grant depending on the availability of funds donated to ETH Foundation. Thomas Zimmermann from Switzerland studying Computational Biology | Bioinformatics is one of the 2024 excellent scholars. An interview.
Open Science rewarded
On 27 November, the Swiss Academies of Arts and Sciences awarded the National Prize for Open Research Data to the Pathoplexus project led by Tanja Stadler and her group member, Software Engineer Chaoran Chen, as well as colleagues from the Biozentrum, University of Basel, and SwissTPH. Together they established the genome sequencing database for viruses of public health relevance. Congratulations!
Treating retina diseases more precisely
With more than 140 million nerve cells, the retina is a highly complex visual system, where it is challenging to treat diseases. A new study by researchers from the Biophysics group of Daniel Müller and colleagues from the Roche Pharma Research and Early Development (pRED) now present an innovative therapeutic approach. The treatment involves attaching viruses to nanoparticles, which are electromagnetically guided to deploy therapeutics exactly where they are needed.
Meet Kerstin Lenhof using machine learning techniques on single-cell level for personalised anti-cancer treatment recommendations
The German Computational Biologist will advance algorithms and statistical tools for drug development in oncology. During her postdoc in the Computational Biology group of Niko Beerenwinkel, Kerstin also plans to explore ethical and societal questions related to machine learning techniques. She enjoys hiking and likes (creating and admiring) art – passions for which Basel clearly is the perfect place.